Biotechs Lose Ground As Achillion Takes a Dive
The Motley Fool
When It Comes To Biotech, Diversity Is Key
Seeking Alpha
Are biotech IPOs already getting too hot to handle?
Fierce Biotech
The Market's Got This Biotech All Wrong
Motley Fool
3 Biotech Companies Ripe for a Takeover
Motley Fool
Biotechs Near Highs In A Week Of Key Earnings Reports
Investors.com

